Page 129 - Bladder Dysfunction in the Context of the Bladder-Brain Connection - Ilse Groenendijk.pdf

REFERENCES
1. Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104(3):352-360.
2. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306-1314; discussion 1314-1305.
3. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760-766.
4. Digesu GA, Khullar V, Cardozo L, Salvatore S. Overactive bladder symptoms: do we need urody- namics? Neurourol Urodyn. 2003;22(2):105-108.
5. Glazener CM, Lapitan MC. Urodynamic studies for management of urinary incontinence in chil- dren and adults. Cochrane Database Syst Rev. 2012;1:CD003195.
6. Nambiar AK, Bosch R, Cruz F, et al. EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence. Eur Urol. 2018;73(4):596-609.
7. Castro Diaz D, Robinson D, Bosch R, et al. Patient-Reported outcome assessment. In: Abrams P, Cardozo L, Wagg A, Wein A, eds. Incontinence. 6th Edition 2017 ed2017:544-598.
8. Foust-Wright C, Wissig S, Stowell C, et al. Development of a core set of outcome measures for OAB treatment. Int Urogynecol J. 2017;28(12):1785-1793.
9. Coyne KS, Thompson CL, Lai JS, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn. 2015;34(3):255-263.
10. Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563-574.
11. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-1736.
12. Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Uro- genital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res. 1994;3(5):291-306.
13. Utomo E, Korfage IJ, Wildhagen MF, Steensma AB, Bangma CH, Blok BF. Validation of the Urogenital Distress Inventory (UDI-6) and Incontinence Impact Questionnaire (IIQ-7) in a Dutch population. Neurourol Urodyn. 2015;34(1):24-31.
14. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-1432.
15. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties
of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42.
16. de Vet HC, Terwee CB, Knol DL, Bouter LM. When to use agreement versus reliability measures. J
Clin Epidemiol. 2006;59(10):1033-1039.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of
clinical measurement. Lancet. 1986;1(8476):307-310.
18. Arlandis S, Ruiz MA, Errando C, et al. Quality of life in patients with overactive bladder: validation
and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form. Clin Drug Investig. 2012;32(8):523-532.
6
The validation of the Dutch OAB-q SF questionnaire 127